IP Verse

Novartis Gene Therapies competitive analysis

Latest publications and patents of Novartis Gene Therapies New

Explore the latest publications and patents granted to Novartis Gene Therapies, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Novartis Gene Therapies

Discover the latest PTAB cases involving Novartis Gene Therapies, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 3, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Novartis Gene Therapies

IPR2023-01045Jun 30, 2023NOVARTIS GENE THERAPIESAVENTISTerminated-Settled
IPR2023-01044Jun 30, 2023NOVARTIS GENE THERAPIESGENZYMETerminated-Settled
IPR2023-00609Feb 22, 2023NOVARTIS GENE THERAPIESGENZYMEInstitution Denied
IPR2023-00608Feb 22, 2023NOVARTIS GENE THERAPIESGENZYMEInstitution Denied

Peer Comparison New

IP litigation analysis comparing Novartis Gene Therapies with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
NOVARTIS GENE THERAPIES - - 4 - Highly Aggressive
AVENTIS - - - 1Non-Active
GENZYME - 1925Defensive